NDC 72934-2048

CLINDAMYCIN 1% / HYDROCORTISONE 2.5% / NIACINAMIDE 4%

Clindamycin 1% / Hydrocortisone 2.5% / Niacinamide 4%

CLINDAMYCIN 1% / HYDROCORTISONE 2.5% / NIACINAMIDE 4% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Hydrocortisone; Niacinamide; Clindamycin Phosphate.

Product ID72934-2048_887a3793-152d-6b7f-e053-2a95a90ab09b
NDC72934-2048
Product TypeHuman Prescription Drug
Proprietary NameCLINDAMYCIN 1% / HYDROCORTISONE 2.5% / NIACINAMIDE 4%
Generic NameClindamycin 1% / Hydrocortisone 2.5% / Niacinamide 4%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-10
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameHYDROCORTISONE; NIACINAMIDE; CLINDAMYCIN PHOSPHATE
Active Ingredient Strength3 g/100g; g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2048-2

30 g in 1 BOTTLE, PUMP (72934-2048-2)
Marketing Start Date2019-05-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2048-2 [72934204802]

CLINDAMYCIN 1% / HYDROCORTISONE 2.5% / NIACINAMIDE 4% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-10

Drug Details

Active Ingredients

IngredientStrength
HYDROCORTISONE2.5 g/100g

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.